The global GMP (Good Manufacturing Practice) testing service market is experiencing steady growth, driven by the rising need for regulatory compliance, increasing pharmaceutical production, and stringent quality assurance requirements across the life sciences industry. GMP testing services ensure that pharmaceutical, biotechnology, and medical device products are consistently produced and controlled according to quality standards, minimizing risks associated with contamination, errors, and product recalls.

The GMP testing service market size is projected to reach US$ 2.64 billion by 2031 from US$ 1.57 billion in 2023. The market is expected to register a CAGR of 6.7% during 2023–2031.

This growth is fueled by the expansion of the pharmaceutical and biotechnology sectors, increasing outsourcing of laboratory testing services, and rising regulatory scrutiny from global health authorities. As drug development pipelines expand, the demand for reliable GMP-compliant testing services continues to rise significantly across both developed and emerging economies.

North America GMP Testing Service Market Competitive Landscape

The North America GMP Testing Service Market competitive landscape is highly structured and competitive, characterized by the presence of leading contract research organizations (CROs), pharmaceutical service providers, and specialized analytical laboratories. North America remains a dominant region due to its strong pharmaceutical manufacturing base, advanced regulatory framework, and high adoption of outsourcing services for quality assurance testing.

Pharmaceutical and biotechnology companies in the region increasingly rely on third-party GMP testing providers to ensure compliance with FDA regulations and international quality standards. The rising complexity of biologics, biosimilars, and advanced therapy medicinal products (ATMPs) has further intensified the need for specialized testing capabilities.

North America Market Highlights

• Strong regulatory oversight by agencies such as the U.S. FDA ensuring strict compliance with GMP standards
• High concentration of pharmaceutical and biotechnology manufacturing facilities
• Growing outsourcing trend toward specialized GMP testing service providers
• Increasing demand for biologics, biosimilars, and cell and gene therapy testing services
• Expansion of contract testing laboratories across the United States and Canada
• Continuous investments in advanced analytical technologies and automation systems

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00029684

Market Drivers and Growth Factors

The GMP testing service market is primarily driven by increasing global pharmaceutical production and the growing complexity of drug development processes. As regulatory frameworks become more stringent, pharmaceutical companies are required to ensure consistent product quality, safety, and efficacy, significantly boosting demand for GMP-compliant testing services.

Another major driver is the rapid growth of biologics and biosimilars, which require highly specialized analytical testing due to their complex molecular structures. Additionally, the rise in clinical trials and the expansion of contract manufacturing organizations (CMOs) are contributing to increased outsourcing of GMP testing services.

Technological advancements such as high-throughput screening, automated analytical systems, and advanced chromatography techniques are also enhancing testing efficiency and accuracy, further supporting market growth.

Competitive Landscape and Top Players

The global GMP testing service market is moderately fragmented, with several global and regional players competing through service expansion, acquisitions, and technological innovation. Companies are increasingly focusing on expanding their laboratory capabilities and geographic reach to meet growing demand from pharmaceutical and biotechnology clients.

Top Players in the GMP Testing Service Market

• Eurofins Scientific
• SGS S.A.
• Intertek Group plc
• Charles River Laboratories International, Inc.
• WuXi AppTec
• Pace Analytical Services LLC
• Labcorp Drug Development
• Merck KGaA (MilliporeSigma Services)
• ALS Limited
• Thermo Fisher Scientific Inc.

These companies are investing in advanced analytical technologies, expanding GMP-certified laboratories, and strengthening their regulatory compliance capabilities to enhance service offerings and global competitiveness.

North America GMP Testing Service Market Trends

North America continues to lead in innovation and adoption of GMP testing services, driven by its highly regulated pharmaceutical industry and strong emphasis on product safety. The region is witnessing a significant shift toward outsourcing analytical testing services to reduce operational costs and improve efficiency.

Key trends shaping the North America market include:

• Rising adoption of automated laboratory testing and digital quality management systems
• Increasing demand for biologics and advanced therapy testing services
• Expansion of GMP-certified contract testing laboratories
• Strong integration of data analytics and AI in quality control processes
• Growing focus on rapid testing solutions to support faster drug approvals

Future Outlook (2031 Perspective)

The future of the GMP testing service market looks highly promising, with continuous growth expected across pharmaceutical, biotechnology, and medical device industries. By 2031, the market is projected to reach US$ 2.64 billion, reflecting the increasing importance of regulatory compliance and quality assurance in global healthcare manufacturing.

North America is expected to maintain its leadership position due to its advanced healthcare infrastructure, strong regulatory environment, and high outsourcing adoption rates. The growing complexity of drug development, particularly in biologics and personalized medicine, will further drive demand for specialized GMP testing services in the region.

In the coming years, the integration of automation, artificial intelligence, and real-time data monitoring is expected to transform GMP testing workflows, improving efficiency, accuracy, and regulatory compliance. Additionally, increasing investments in cell and gene therapy research will create new opportunities for advanced analytical testing services.

Overall, the GMP Testing Service Market is set for sustained expansion through 2031, with North America playing a central role in driving innovation, regulatory excellence, and service adoption across the global pharmaceutical landscape.

Top Trending Reports:

Microbiology Laboratory Automation Market Size, Share & Demand by 2034

Genetic Testing Services Market Segments and Growth by 2031

About Us

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us

The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com

Also Available in: Korean German Japanese French Chinese Italian Spanish